Home
Log In
Shipping
Information
Contact Us
Advanced Search
DISEASES & HEALTH CONDITIONS->
GENERAL HEALTH->
MEDICAL & SURGICAL
->
MEDICAL SPECIALTIES->
MENTAL HEALTH->
NURSING->
NURSING EQUIPMENT
PHARMACEUTICAL->
Stemcells
VETERINARY->
CHARTS & MODELS
VOUCHERS
CLEARANCE TITLES
FEATURED PRODUCTS ...
Home
/
MEDICAL & SURGICAL
/
E - G
/
General Medicine
/
Pharmaceutical Economics and Policy
General Medicine
Product 2902/4841
Previous
Return to the Product List
Next
Pharmaceutical Economics and Policy
larger image
ISBN 9780195300956
Author: SCHWEITZER
Publ Date: 2006-11-27
Edition:
Binding: Hardback
$186.96
Sale: $168.26
Save: 10% off
+ GST
Add to Cart:
The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of
maximizing shareholder value, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand the complexities of the industry and its role in the nations
healthcare system. This book uses the tools of economic analysis to explore the conflicting priorities and aims of the pharmaceutical industry, from both an American and worldwide perspective.This is the second edition of a uniquely comprehensive and balanced discussion of pharmaceutical policy issues. All the chapters of the former edition have been fully re-written and extensively updated.In addition, the book includes six new chapters on emerging
topics such as the broadened role of FDA regulations and the increasing diversity of the industry. An entire chapter is devoted to the biotechnology industry and one to alternative medicines, often
called "nutraceuticals." Another new chapter discusses segments of the industry that specialize in particular activities including generic drugs and drug delivery systems. The recent controversial expansion of Medicare to cover outpatient drugs is discussed in depth. The introduction is also updated to address the volatile pace of pharmaceutical innovation and how the pharmaceutical industry has responded to the emergence of managed care.
Whilst every effort is made to keep pricing information up-to-date, prices and availability are subject to change without notice. Where prices or other details have changed from those listed on the website we will contact the customer and only proceed with the order after receiving acceptance of the revised pricing.
Pharmaceutical Economics and Policy
Home
Your IP Address is: 3.147.66.224
Copyright © 2024
Medical Books
. Powered by
Zen Cart